CTOs on the Move

Equideum Health

www.equideum.health

 
Equideum Health creates Web3 person-centered healthcare and research networks to advance health equity and outcomes by optimizing data liquidity across enterprise and individual data silos, powered by Ethereum.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Jonathan Holt
Chief Medical Informatics Officer and Senior Technical Fellow Profile
William Gleim
Chief Technology Officer Profile
Debbie Bucci
Chief Data Officer Profile

Similar Companies

SCR Medical Transportation

SCR Medical Transportation is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CommunityCare of Oklahoma Health Insurance Plans

CommunityCare, one of the largest health care companies in Oklahoma, is locally owned and operated by Saint Francis Health System and St. John Health System in Tulsa. CommunityCare offers a wide variety of group and individual products, including HMO, HRA, POS and PPO plans, Medicare Advantage plans, Medicare supplement plans, an employee assistance program and a workers` compensation plan. CommunityCare is proud to be Oklahoma`s best choice for health care.

Governor'S Glen Memory Imprd

Governor'S Glen Memory Imprd is a Forest Park, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Aiken Regional Medical Centers

Aiken Regional Medical Centers is a Aiken, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Furiex

Furiex Pharmaceuticals, Inc., a drug development company, engages in the compound partnering business primarily in the United States. It collaborates with pharmaceutical and biotechnology companies to enhance the value of their drug candidates by applying its novel approach to drug development. The company’s products under development include Eluxadoline1, a mu opioid receptor agonist and delta opioid receptor antagonist, which is in Phase III clinical trials for the treatment of diarrhea-predominant irritable bowel syndrome; and Avarofloxacin1, a Phase III-ready fluoroquinolone antibiotic for the treatment of acute bacterial skin and skin structure infections. It is also developing SYR-472, which is in Phase III clinical trials for the treatment of Type-2 diabetes. In addition, the company has rights to compounds in various stages of development and commercialization, which includes Nesina, Liovel, Oseni, and Kazano for the treatment of Type-2 diabetes, as well as Priligy for the treatment of premature ejaculation. The company was founded in 1998 and is headquartered in Morrisville, North Carolina.